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Abstract
Background: Complications to femoral artery puncture may result in formation of a pseudo-
aneurysm (PSA). We investigated whether PSA obliteration may be achieved by compression
dressing repair (CDR) and sought to determine the predictors of successful CDR.
Methods: Sixty two patients (30 male, mean age 61.0 ± 12.8) with femoral PSAs due to
cardiac catheterization were included in the study. In all patients, duplex ultrasound followed
by CDR was performed to evaluate PSA morphology and flow velocities in the PSA neck.
Results: Forty six (74.2%) patients did not respond to CDR. Predictors of successful CDR
were forward [0.18 (0.07–0.47), p = 0.0004] and reverse [0.08 (0.02–0.33), p = 0.0006] flow
velocities in the PSA neck. The forward velocity was identified as an independent predictor of
CDR outcome (p = 0.02).
Conclusions: Compression dressing repair may serve as an alternative method of femoral
pseudoaneurysm management in patients with low forward and reverse velocities of the flow
in pseudoaneurysm neck. The forward velocity is an independent predictor of compression
dressing repair result. (Cardiol J 2010; 17, 2: 179–183)
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Introduction
Complications to femoral artery puncture may
result in the formation of a pseudoaneurysm (PSA)
in 0.1–6% of cases [1–3]. In the 1990s, ultrasound-
guided compression repair (UGCR) and then ultra-
sound-guided thrombin injection (UGTI) replaced
traditional surgical management of PSAs as first line
therapy [4–6]. UGTI was found to be superior to
UGCR [7, 8]. However, thrombin injection may
cause allergic reactions, particularly in patients pre-
viously exposed to bovine thrombin [9] or in periph-
eral embolization [8, 10]. Paschalidis et al. [11] pro-
posed manual compression without ultrasound
surveillance as an alternative method of PSA man-
agement. It was proved as successful and safe as
UGCR, and more comfortable, both for the patient
and the operator.
We investigated whether PSAs obliteration
may be achieved by blind compression dressing
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repair (CDR) and sought to determine the selection
criteria to predict which femoral PSAs would re-
spond to this kind of therapy.
Methods
Between January 2003 and December 2008,
36,359 cardiac catheterizations (20,315 diagnostic,
16,044 therapeutic) were performed at our institu-
tion. Post-catheterization care included manual
compression at the puncture site followed by compres-
sion dressing application for 24 hours. In individual
patients (those who were obese, had a history of venous
thrombosis, or were on anticoagulants) closure de-
vices such as the Star-Close System were used.
Patients with evidence of haematoma, pulsa-
tile mass in the groin, bruit over puncture site, limb
neuropathy or perfusion deficit underwent routine
Doppler duplex examination in order to reveal com-
plications of femoral artery puncture. Duplex ultra-
sound was carried out by an experienced sonogra-
pher with Vingmed VIVID-3 and VIVID-5 (Gene-
ral Electrics Horten Norway) equipped with
transducers ranging from 3.5 to 10 MHz and record-
ed on magneto-optic disc. PSA evaluation included
identification of the punctured artery, number of
lobes, size (length, width, height, volume of the
open cavity), neck morphology (width, length), dy-
namics of the flow in the PSA neck [maximal for-
ward (Vf) and reverse (Vr) velocities] with ultra-
sound beam parallel to flow direction in the PSA
neck. PSAs were defined according to the number
of lobes as simple (1 lobe) or complex (> 1 lobe).
Patients were offered three methods of PSA
management: CDR, UGTI or surgical repair. Tra-
ditional compression repair with ultrasound trans-
ducer or blind manual compression were not used
in this study. Patients with femoral artery PSAs who
objected to UGTI or surgical repair as a first line
treatment, and decided to undergo CDR, were in-
cluded in the study. All the patients gave their in-
formed consent. Exclusion criteria for CDR were:
location above the inguinal ligament, skin necrosis
or infection over pulsatile mass, limb neurological
or perfusion deficit, concomitant anticoagulation
therapy. The CDR technique involved marking on
the skin the site over PSA neck and precise appli-
cation of compression dressing. Compression dress-
ing was formed of 'tissue bubble' which was held in
the desired place with an elastic band around the
patient. The band was tightened in order to arrest
or reduce the flow into the PSA cavity but without
significantly compromising the flow in the under-
lying artery which was confirmed by Doppler. In the
presence of complex PSA, compression dressing
was placed over the neck communicating the fem-
oral artery with PSA proximal cavity. CDR was ap-
plied for a maximum of 48 hours. Patients were
advised to remain immobile until CDR was termi-
nated. Every 12–24 hours PSA was reassessed on
duplex ultrasound to evaluate the progression of
thrombosis within PSA or possible complications
such as PSA rupture, vein thrombosis or distal ar-
tery embolization. Evidence of any complications or
complete PSA obliteration resulted in CDR termi-
nation within 48 hours from the onset of the proce-
dure. Duplex ultrasound was repeated 24 hours af-
ter successful thrombosis to confirm PSA closure.
Alternative treatment such as UGTI or surgical
repair was offered to patients in whom CDR failed
to obliterate PSA.
Statistical analysis
All values were expressed as mean ± standard
deviation. P value < 0.05 was required to fulfil sta-
tistical significance. Differences between success-
ful and failed compression groups were evaluated
by Student’s unpaired test for continuous variables
and analysis for discreet variables. Consecutive
Doppler parameters were incorporated into univari-
ate logistic regression model, which considered
echo-parameters as independent variables and the
result of compression therapy as a dependent va-
riable. Receiver operating characteristics (ROC) ana-
lysis was used to evaluate the prognostic value of
CDR predictors. The parameters which influenced
CDR-probability with a significance level of p < 0.05
entered multivariate logistic regression analysis to
determine the independent association of duplex
ultrasound parameters with CDR outcome. A cut-
off value of p < 0.05 was used to determine entry
of the next parameter into the model. Diagnostic
performance of the most powerful independent pre-
dictor of CDR at various thresholds was used to
generate a receiver operating characteristic (ROC)
curve. All calculations were performed using a com-
mercially available statistical package SAS 9.1.3
(SAS Institute Inc., Cary, NC, USA).
Results
In 123 patients (51 male, mean age 61.4 ± 12.7)
iatrogenic PSAs (121 femoral and two iliac exter-
nal) were discovered on duplex ultrasound 3.8 ±
± 2.7 days post-catheterization. In all the patients,
compression dressing application was followed by
standard post-catheterization care with manual
compression. The complication rate of cardiac cath-
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eterization was 0.34%. Three patients were prima-
rily referred for surgical repair because of PSA lo-
cation above inguinal ligament (n = 1) and limb
perfusion deficit (n = 2). In 40 patients UGTI was
performed as the first line treatment as decided by
the patients. Eighteen patients were excluded from
the study due to concomitant anticoagulation ther-
apy (heparin, dicumarol). The study group consist-
ed of 62 patients (30 male, mean age 61.0 ± 12.8)
in whom CDR was attempted. For clinical charac-
teristics, see Table 1.
Diagnostic cardiac catheterization was per-
formed in 17 patients and 45 patients underwent in-
terventional procedures. In all patients catheter size
6 F was used. On duplex ultrasound 41 simple and
21 complex PSAs (2–4 lobes) were identified. PSA
morphology characteristics are presented in Table 2.
In 16 (25.8%) patients CDR successfully closed
PSA. Mean compression time was 41.8 ± 11.1
hours. The time of successful compression did not
differ significantly between simple and complex
PSAs (44.5 ± 9.5 vs 38.3 ± 13.3 h, p = 0.12). Three
(4.8%) patients were referred for surgical treatment
due to PSA rupture and haemorrhage during CDR.
In the other 43 (69.4%) patients, successful UGTI
was performed.
No statistically significant differences were not-
ed for age, sex, and concomitant medications between
groups with successful and failed CDR (Table 1).
Univariate analysis of PSA morphology identified
Vf and Vr as predictors of successful CDR (Table 3).
Cut-off  Vf =2.8 m/s would predict the result of
compression therapy with 86.7% sensitivity and
79.6% specificity and Vr = 1.4 m/s with 86.7% sensi-
Table 1. Study group characteristics.
Successful CDR (n = 16) Failed CDR (n = 46) p
Age 59.1 ± 14.8 61.7 ± 12.1 0.29
Gender (male) 7 (38.8%) 19 (41.3%) 0.91
Body mass index 30.1 ± 2.6 28.3 ± 3.1 0.17
Procedures:
Coronary angiogram 5 (31.3%) 12 (26.1%) 0.83
Therapeutic: 11 (68.7%) 34 (73.9%) 0.74
     Coronary stenting 8 (50%) 32 (69.7%)
     Peripheral stenting 2 (12.5%) 1 (2.1%)
     Amplatzer insertion 1 (6.2%) 1 (2.1%)
Surgery 0 1 (2.1%)
Aspirin 14 (87.5%) 41 (89.1%) 0.87
Aspirin + clopidogrel 11 (68.8%) 34 (73.9%) 0.74
CDR — compression dressing repair
Table 2. Characteristics of pseudoaneurysm (PSA) morphology.
PSA characteristics Successful CDR (n = 16) Failed CDR (n = 46) p
Location:
Common femoral artery 15 (93.8%) 22 (66.7%) 0.08
Superficial femoral artery 1 (6.2%) 11 (33.3%) 0.09
Length [mm] 22 ± 9 26 ± 9 0.19
Depth [mm] 16 ± 7 16 ± 5 0.94
Width [mm] 15 ± 7 18 ± 6 0.17
Volume [mL] 3.6 ± 2.6 4.7 ± 3.4 0.28
Neck width [mm] 3.2 ± 2.9 3.4 ± 1.4 0.71
Neck length [mm] 7.8 ± 4.1 8.0 ± 4.4 0.90
Forward velocity [m/s] 2.2 ± 0.8 3.8 ± 1.2 < 0.0001
Reverse velocity [m/s] 0.9 ± 0.4 1.9 ± 0.4 < 0.0001
CDR — compression dressing repair
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tivity and 72.9% specificity. By multivariate analysis
Vf was identified as an independent predictor of suc-
cessful CDR (p = 0.02). The diagnostic performance
of Vf was used to generate ROC curve (Fig. 1).
Discussion
Iatrogenic PSAs develop as the result of fail-
ure to seal the arterial puncture and the blood jet
creates a cavity in the surrounding tissues. Com-
plications of PSA formation include haemorrhage,
skin and tissue ischemia, and distal embolization.
Several studies have reported spontaneous throm-
bosis of PSAs not exceeding 35 mm in diameter,
6 mL in volume or with progressive centripetal throm-
bus formation [12–14]. However, failure in obliter-
ation of small PSAs was also observed and no defi-
nite data for safe and conservative PSA manage-
ment has been established yet [14]. In 1991
traditional surgical management of iatrogenic PSAs
was replaced by UGCR, first introduced by Fellmeth
et al. [4]. Early reports showed excellent results of
UGCR with regard to safety and efficacy. Howev-
er, this method has several drawbacks. UGCR is
time-consuming, uncomfortable for the patient, who
frequently cannot endure the procedure without
analgesia and/or sedation, and for the operator.
Modification of this method, such as manual compres-
sion without ultrasound guidance, was found to be as
successful and safe as UGCR but more comfortable
for the patient and less fatiguing for the operator [11].
Concomitant anticoagulation or antiplatelet therapy
increases failure of compression repair and reopen-
ing rate [15–17]. This method, however, is not free
of complications such as rupture, distal embolization
or vein thrombosis and should not be applied in pa-
tients with PSAs located above inguinal ligament,
large haematomas, skin ischemia or infection, limb
perfusion or neurological deficit.
In the present study, we tested a less aggres-
sive method of PSA obliteration, i.e. compression
dressing application in order to reduce the flow into
PSA cavity and enable spontaneous thrombosis. Our
results showed much higher failure rate of 74.2%
compared to the results of UGCR. This can be ex-
plained by a number of factors.
Firstly, we used a different protocol for com-
pression repair. Although the therapy was continued
with precise compression dressing application, we
could not provide any evidence that the flow veloci-
ties in the PSA neck were reduced during compres-
sion. Secondly, our study group consisted of patients
treated with antiplatelet medications. Over 75% of
patients were receiving dual antiplatelet therapy (as-
pirin, clopidogrel or ticlopidine) during CDR.
Our study showed a significant relationship
between the dynamics of the flow in the PSA neck
and the results of compression repair.
Forward and reverse velocities in the PSA neck
were found to be excellent predictors of CDR out-
come. To the best of our knowledge, this is the first
study reporting such a relationship. Kent et al. [14]
analyzed velocity of flow in the PSA cavity. Their
findings showed insignificantly decreased velocities
in PSAs that thrombosed spontaneously, compared
to PSA which failed to close without any interven-
tion. However, as the authors point out, swirling
blood flow within the PSA cavity made the adjust-
ment of insonation angle and accurate velocity mea-
surement very difficult.
According to our protocol, we measured for-
ward and reverse velocities in the PSA neck. The
forward velocity in the PSA neck was identified as
Table 3. Logistic regression: univariate analysis
— predictors of successful compression.
Variable OR/unit (± 95% CI) p
Forward velocity 0.18 (0.07–0.47) 0.0004
Reverse velocity 0.08 (0.02–0.33) 0.0006
OR — odds ratio, CI — confidence interval
Figure 1. Receiver-operating characteristics curve for
the forward velocity of the neck-through flow for the
discrimination of successful compression repair; Vf —
forward velocity in pseudoaneurysm neck.
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an independent prognostic factor of CDR. Vigorous
inflow into PSA cavity and, in consequence, high
pressure gradient between femoral artery and PSA
cavity, make PSA compression difficult. Further-
more, high-velocity blood stream may prevent PSA
obliteration by mechanical disruption of the throm-
bus. In contrast to other studies [13–14] we did not
observe a relationship between the PSA size and
compression repair result (Table 2). This can be
explained by the different compression repair meth-
od, aiming at a reduction, but not cessation, of in-
flow into the PSA cavity.
Clinical implications
Despite the fact that the overall success of CDR
was unsatisfactory, we were able to identify and
measure Doppler parameters that separate com-
pressible from non-compressible PSAs. Therefore,
we showed that in patients without anticoagulation
therapy and low forward and reverse velocities into
PSA cavity, CDR may serve as an alternative meth-
od of femoral PSA management. This finding is es-
pecially relevant in areas in which thrombin injec-
tions or ultrasound guided compression repair is not
available.
Limitations of the study
The major limitation of the study is the tech-
nique of CDR. The same compression strength
could not be applied to all the patients due to their
body mass. There was no method to measure or
compare it. Furthermore, it was not possible to
evaluate whether any restriction of inflow into the
PSA cavity was achieved under compression.
Therefore, the reproducibility of the compression
technique remains in question. However, the ma-
jor findings of this study identifying unfavorable
PSA morphology should still be helpful in making
decisions regarding the method of PSA treatment.
Conclusions
We conclude that compression dressing repair
may serve as an alternative method of femoral
pseudoaneurysm management in patients with low
forward and reverse velocities of the flow in
pseudoaneurysm neck. The forward velocity was
identified as an independent predictor of compres-
sion dressing repair outcome.
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